India is the largest supplier of generic medicines in the world, exporting over USD 50 billion worth of pharmaceuticals annually. Indian generics fill approximately 40% of the US generic drug…
The United States imposed a sweeping 100% tariff on patented pharmaceutical imports on April 2, 2026, under Section 232 of the Trade Expansion Act. However, generic medicines — which make…
🔬 How CDSCO Monitors Drug Quality in India: Understanding NSQ Alerts, Factory Inspections & What International Buyers Should Know India is one of the world's largest producers of generic medicines,…
India's Central Drugs Standard Control Organisation (CDSCO) is embarking on the most significant regulatory restructuring in its history. In a move designed to strengthen pharmaceutical quality oversight and align with…